Find a Doctor

Beverly J. Lange, MD

Medical Director, Oncology Clinical Services and Clinical Research

Attending physician

Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Awards

2006, Temple University School of Medicine Alumni Achievement Award

2006, American Board of Pediatrics, Hematology/Oncology Self Assessment Subcommittee, April 28, 29: Rosenthal Foundation USCF School of Medicine Faculty Mentor

2005, Member, Board of Trustees, Bryn Mawr College School of Social Work and Social Research

2004-07, Bryn Mawr College Board of Trustees, Special Representative

2003-Present, Children's Oncology Group

  • Executive Committee
  • Scientific Council

Associate Chair, Cancer Control Discipline Committee

2002-Present, President ASPHO

2001-2004, Best Doctors in America

1999, President Elect and Trustee ASPHO

1998, Who's Who in Science and Engineering

1998, Chairperson: Directors of Pediatric Hematology/Oncology Fellowship

1998, Chairperson: American Board of Pediatrics: Sub-Board Pediatric Hematology-Oncology

1997-2003, Member, Board of Trustees, Bryn Mawr College1996, Best Doctors in America, American Health

1997, World Class Physician, Philadelphia Magazine

1996, The Robert Dunning Dripps Award for Excellence in Post-Graduate Teaching in Medicine

1996, International Who's Who of Professionals

1994, Listed in the Best Doctors in America, published by Woodward/White, Inc.

1993, Member: American Board of Pediatrics: Sub-board Pediatric Hematology-Oncology

1992, John Morgan Society

1992, American Pediatric Society

1980-1983, American Cancer Society, Junior Faculty Clinical Fellowship

1967-1970, Harriet Swain Memorial Medical Scholarship

Books

Lange B, Close P, Danz P, Horning D, Sherer DA, Belasco J. Home infusion therapy for the child with cancer. The Children's Hospital of Philadelphia, 1992.

Editorial and Academic Positions

Editorial positions

Reviewer

2004-present Pediatric Blood and Cancer
2002-present American Journal of Hematology
2002-present New England Journal of Medicine
2000-present The Oncologist
2000-present Infection Control and Hospital Epidemiology
1999-present British Journal of Haematology
1996-present Nature Medicine
1993-present Annals of Internal Medicine
1993-present American Journal of Pediatric Hematology/ Oncology
1993-present Medical and Pediatric Oncology
1991-present Journal of Clinical Oncology
1988-present Blood
1988-present Cancer Research
1988-present Journal of Pediatrics
1980-present Cancer

Leadership

Memberships in professional organizations

1994-present American Society of Hematology
1990-present American Society of Pediatric Hematology/Oncology
1989-present Fellow American Academy of Pediatrics
1981-present American Society of Clinical Oncology
1979-present Philadelphia Pediatric Society
1979-present Children's Cancer Study Group (CCSG/CCG)

Participation in scientific committees

Children's Cancer Group committees

  • 1986-present CCG ANLL Strategy Group: member
  • 1987-present CCG 1891 Therapy for Intermediate Risk ALL: Chair
  • 1995-present CCG-2961 Previously Untreated AML: Chair
  • 1996-present CCG AML Strategy Group: Steering Committee

Original Papers

2011

Lange BJ, Yang RK, Gan J, Hank JA, Sievers EL, Alonzo TA, et al. Soluble interleukin-2 receptor αactivation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2011 Sep;57(3):398-405. doi: 10.1002/pbc.22966. Epub 2011 Jun 16. Cited in PubMed: PMID 21681921. Read the abstract

Johnston DL, Alonzo TA, Berbing RB, Lange BJ, Woods WG. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. Epub 2011 May 25. doi: 10.1002/pbc.23201. Cited in PubMed: PMID 21618422. Read the abstract

Sepe DM, McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, et al. Germline genetic variation and treatment response on CCG-1891. Pediatr Blood Cancer. Epub 2011 May 25. doi: 10.1002/pbc.23192. Cited in PubMed: PMID 21618417. Read the abstract

Buyse M, Squifflet P, Lange BJ, Alonzo TA, Larson RA, Kolitz JE, et al. Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia. Blood. 2011 Jun 30;117(26):7007-13. Epub 2011 Apr 25. Cited in PubMed: PMID 21511893. Read the abstract

2010

Johnston DL, Alonzo TA, Berbing RB, Lange BJ, Woods WG. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep;55(3):414-20. Cited in PubMed: PMID 20658610. Read the abstract

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML. Blood. 2010 Mar 25;115(12):2372-9. Epub 2010 Jan 7. Cited in PubMed: PMID 20056794. Read the article

« Back to Previous Page
  • Print
  • Share

Contact Us